Express Scripts Holding (ESRX)
$92.33 0.00 (0.00%)
19:46 EST ESRX Stock Quote Delayed 15 Minutes
Previous Close -
Market Cap 51.86B
PE Ratio 11.63
Volume (Avg. Vol.)
Day's Range 92.33 - 92.33
52-Week Range -
Dividend & Yield N/A (N/A)
ESRX Stock Predictions, Articles, and Express Scripts Holding News
- From InvestorPlace
- From the Web
Low valuations and strong growth make these cheap stocks attractive buys. Here's what investors need to know about each stock.
ExpressScripts stock (ESRX) is not moving late in the day as the company reported its quarterly earnings results, which beat estimates.
Cigna stock will be boosted by the merger of Cigna and Express Scripts Holding Co. In the wake of the deal, CIT stock looks cheap.
Cigna is one step closer to a buyout of ESRX after approval from the Department of Justice. Here's what CI stock investors should expect.
Express Scripts (NASDAQ:ESRX), a pharmacy benefit management company operating in the United States and Canada, reported its latest earnings this past Wednesday, Aug. 1, and the stock moved sharply lower when the report crossed the tape.
Stock charts of Express Scripts, Ventas and Alexion Pharmaceuticals are shaping up as your best bets as the week nears its end.
CI stock is trading at over 20% below its yearly high, and it's discounted ahead of the Express Scripts deal. Investors will want to consider Cigna's long-term upside when the deal closes.
The Trump administration is targeting PBMs, so it's time to sell PBM stocks, including CVS stock and Express Scripts stock.
Be wary of a misleading article from Axios about Pharmaceutical Benefit Managers.
Analysts are skeptical that buying the largest Pharmacy Benefit Manager will help make Cigna -- one of the smaller health insurers -- more profitable.
The U.S. MedTech markets have been riding high with merger and acquisitions in focus. Compare Brokers...
Cigna is paying more than its own market cap for ExpressScripts, the largest Pharmacy Benefit Manager.
Stocks finished mixed on Thursday as President Trump finally unveiled the steel and aluminum tariffs that were hinted at last week.
Express Scripts (ESRX) stock was on the rise Thursday following news of a deal with Cigna (CI) that will have the two companies merging together.
3 Stocks to Watch on Wednesday: Celgene Corporation (CELG), e.l.f. Beauty Inc (ELF) and Express Scripts Holding Company (ESRX)
Celgene's (CELG) drug application is turned down by FDA, e.l.f. Beauty (ELF) misses revenue outlook and Express Scripts (ESRX) earnings beat estimates.
Morgan Stanley listed 15 prime takeover candidates for the next 12 months and TipRanks shows us which among those are your best investing bets.
Healthcare stocks were rocked hard this week, but they will recover. The news that Amazon, Berkshire Hathaway and JPMorgan are forming their own healthcare company will not hold other healthcare stocks down for the long-term.
The new venture being launched by Warren Buffett, JPMorgan Chase and Amazon.com will badly hurt PBM stocks, including ESRX, CVS and WBA.
UnitedHealth (UNH) stock is down on an Amazon (AMZN) headline. I bet this dip is not the start of something more sinister, so here's how you can catch this proverbial falling knife.
From Real Money